Fatimah I. Qassadi
Plant-Derived Products with Therapeutic Potential against Gastrointestinal Bacteria
Qassadi, Fatimah I.; Zhu, Zheying; Monaghan, Tanya M.
Authors
Dr ZHEYING ZHU Zheying.Zhu@nottingham.ac.uk
ASSOCIATE PROFESSOR IN INTERNATIONAL PHARMACY AND TRADITIONAL MEDICINES
Dr TANYA MONAGHAN Tanya.Monaghan@nottingham.ac.uk
CLINICAL ASSOCIATE PROFESSOR IN LUMINAL GASTROENTEROLOGY
Abstract
The rising burden of antimicrobial resistance and increasing infectious disease outbreaks, including the recent COVID-19 pandemic, has led to a growing demand for the development of natural products as a valuable source of leading medicinal compounds. There is a wide variety of active constituents found in plants, making them an excellent source of antimicrobial agents with therapeutic potential as alternatives or potentiators of antibiotics. The structural diversity of phytochemicals enables them to act through a variety of mechanisms, targeting multiple biochemical pathways, in contrast to traditional antimicrobials. Moreover, the bioactivity of the herbal extracts can be explained by various metabolites working in synergism, where hundreds to thousands of metabolites make up the extract. Although a vast amount of literature is available regarding the use of these herbal extracts against bacterial and viral infections, critical assessments of their quality are lacking. This review aims to explore the efficacy and antimicrobial effects of herbal extracts against clinically relevant gastrointestinal infections including pathogenic Escherichia coli, toxigenic Clostridioides difficile, Campylobacter and Salmonella species. The review will discuss research gaps and propose future approaches to the translational development of plant-derived products for drug discovery purposes for the treatment and prevention of gastrointestinal infectious diseases.
Citation
Qassadi, F. I., Zhu, Z., & Monaghan, T. M. (2023). Plant-Derived Products with Therapeutic Potential against Gastrointestinal Bacteria. Pathogens, 12(2), Article 333. https://doi.org/10.3390/pathogens12020333
Journal Article Type | Review |
---|---|
Acceptance Date | Feb 14, 2023 |
Online Publication Date | Feb 15, 2023 |
Publication Date | Feb 15, 2023 |
Deposit Date | Feb 20, 2023 |
Publicly Available Date | Feb 21, 2023 |
Journal | Pathogens |
Electronic ISSN | 2076-0817 |
Publisher | MDPI |
Peer Reviewed | Peer Reviewed |
Volume | 12 |
Issue | 2 |
Article Number | 333 |
DOI | https://doi.org/10.3390/pathogens12020333 |
Keywords | Plant-derived products; antibiotic resistance; new drug targets; gastrointestinal infections; clinical trials |
Public URL | https://nottingham-repository.worktribe.com/output/17386494 |
Publisher URL | https://www.mdpi.com/2076-0817/12/2/333 |
Files
Plant-Derived Products with Therapeutic Potential against Gastrointestinal Bacteria
(602 Kb)
PDF
Publisher Licence URL
https://creativecommons.org/licenses/by/4.0/
You might also like
P102 Dissecting the metabolic impact of faecal microbiota transplantation (FMT) in C. difficile and E. coli infections using 3D OrbiSIMS
(2024)
Presentation / Conference Contribution
Downloadable Citations
About Repository@Nottingham
Administrator e-mail: discovery-access-systems@nottingham.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2025
Advanced Search